Internet-based Support for Informal Caregivers of Patients With Head and Neck Cancer - Carer eSupport
- Disease/Condition
- Head and Neck Cancer
- Drug/Device/Intervention
- Carer eSupport
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Uppsala University
- Location
- Örebro,Uppsala,Umeå,Göteborg, Sweden
- Phase
- N/A
- Start date
- May 06, 2024
- End date
- Oct 31, 2025
- Enrollment
- 110 participants
The self-reported questionnaire Preparedness for caregiving scale
The aim of this randomized controlled trial is to investigate the effects of internet-based
 support (Carer eSupport) on preparedness for caregiving in informal caregivers of patients
 with head and neck cancer. The main question[s] it aims to answer are:
 
 - What are the effects of internet-based support on informal caregivers preparedness for
 caregiving?
 
 - What are the effects of internet-based support on informal caregivers burden and
 wellbeing?
 
 Informal caregivers who are randomized to Carer eSupport will have access to Carer eSupport
 for 18 weeks and they will be asked to complete questionnaires (outcome measures) at:
 
 - baseline (before randomization)
 
 - 18 weeks (post-intervention) and at
 
 - 3 months after the intervention is completed (long term follow-up).
 
 Informal caregivers in the intervention group will be compared to informal caregivers who
 receive standard care support regarding preparedness for caregiving, caregiver burden and
 wellbeing.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06307418
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06307418 through Pure Global AI's free database. This phase not specified trial is sponsored by Uppsala University and is currently Not yet recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 110 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.